img

Global Dimenhydrinate Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dimenhydrinate Market Research Report 2024

Dimenhydrinate, also known as Dramamine or Gravol, is an over-the-counter drug used to prevent nausea, vomiting, and dizziness caused by motion sickness.
According to Mr Accuracy reports’s new survey, global Dimenhydrinate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dimenhydrinate market research.
Key manufacturers engaged in the Dimenhydrinate industry include Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories, Pfizer, Nexgen Pharma, Goodwill Pharma, Hennig Arzneimittel, Zambon and Apotex, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Dimenhydrinate were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Dimenhydrinate market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dimenhydrinate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bristol-Myers Squibb
Baxter Healthcare
Watson Laboratories
Pfizer
Nexgen Pharma
Goodwill Pharma
Hennig Arzneimittel
Zambon
Apotex
Teva
Mylan
Cinfa
Neuraxpharm Arzneimittel
Gedeon Richter
Medrock Biotech
Strides Pharma
Fresenius
Novartis
Johnson and Johnson
Yoshindo
IFET
Bayer
Nidda Healthcare
Medifarma
Segment by Type
Oral
Injection

Segment by Application


Hospital
Drug Store
On-line

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dimenhydrinate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Dimenhydrinate Market Overview
1.1 Product Overview and Scope of Dimenhydrinate
1.2 Dimenhydrinate Segment by Type
1.2.1 Global Dimenhydrinate Market Value Comparison by Type (2024-2034)
1.2.2 Oral
1.2.3 Injection
1.3 Dimenhydrinate Segment by Application
1.3.1 Global Dimenhydrinate Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 On-line
1.4 Global Dimenhydrinate Market Size Estimates and Forecasts
1.4.1 Global Dimenhydrinate Revenue 2018-2034
1.4.2 Global Dimenhydrinate Sales 2018-2034
1.4.3 Global Dimenhydrinate Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Dimenhydrinate Market Competition by Manufacturers
2.1 Global Dimenhydrinate Sales Market Share by Manufacturers (2018-2024)
2.2 Global Dimenhydrinate Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Dimenhydrinate Average Price by Manufacturers (2018-2024)
2.4 Global Dimenhydrinate Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Dimenhydrinate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dimenhydrinate, Product Type & Application
2.7 Dimenhydrinate Market Competitive Situation and Trends
2.7.1 Dimenhydrinate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dimenhydrinate Players Market Share by Revenue
2.7.3 Global Dimenhydrinate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dimenhydrinate Retrospective Market Scenario by Region
3.1 Global Dimenhydrinate Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Dimenhydrinate Global Dimenhydrinate Sales by Region: 2018-2034
3.2.1 Global Dimenhydrinate Sales by Region: 2018-2024
3.2.2 Global Dimenhydrinate Sales by Region: 2024-2034
3.3 Global Dimenhydrinate Global Dimenhydrinate Revenue by Region: 2018-2034
3.3.1 Global Dimenhydrinate Revenue by Region: 2018-2024
3.3.2 Global Dimenhydrinate Revenue by Region: 2024-2034
3.4 North America Dimenhydrinate Market Facts & Figures by Country
3.4.1 North America Dimenhydrinate Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Dimenhydrinate Sales by Country (2018-2034)
3.4.3 North America Dimenhydrinate Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dimenhydrinate Market Facts & Figures by Country
3.5.1 Europe Dimenhydrinate Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Dimenhydrinate Sales by Country (2018-2034)
3.5.3 Europe Dimenhydrinate Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dimenhydrinate Market Facts & Figures by Country
3.6.1 Asia Pacific Dimenhydrinate Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Dimenhydrinate Sales by Country (2018-2034)
3.6.3 Asia Pacific Dimenhydrinate Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dimenhydrinate Market Facts & Figures by Country
3.7.1 Latin America Dimenhydrinate Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Dimenhydrinate Sales by Country (2018-2034)
3.7.3 Latin America Dimenhydrinate Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dimenhydrinate Market Facts & Figures by Country
3.8.1 Middle East and Africa Dimenhydrinate Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Dimenhydrinate Sales by Country (2018-2034)
3.8.3 Middle East and Africa Dimenhydrinate Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dimenhydrinate Sales by Type (2018-2034)
4.1.1 Global Dimenhydrinate Sales by Type (2018-2024)
4.1.2 Global Dimenhydrinate Sales by Type (2024-2034)
4.1.3 Global Dimenhydrinate Sales Market Share by Type (2018-2034)
4.2 Global Dimenhydrinate Revenue by Type (2018-2034)
4.2.1 Global Dimenhydrinate Revenue by Type (2018-2024)
4.2.2 Global Dimenhydrinate Revenue by Type (2024-2034)
4.2.3 Global Dimenhydrinate Revenue Market Share by Type (2018-2034)
4.3 Global Dimenhydrinate Price by Type (2018-2034)
5 Segment by Application
5.1 Global Dimenhydrinate Sales by Application (2018-2034)
5.1.1 Global Dimenhydrinate Sales by Application (2018-2024)
5.1.2 Global Dimenhydrinate Sales by Application (2024-2034)
5.1.3 Global Dimenhydrinate Sales Market Share by Application (2018-2034)
5.2 Global Dimenhydrinate Revenue by Application (2018-2034)
5.2.1 Global Dimenhydrinate Revenue by Application (2018-2024)
5.2.2 Global Dimenhydrinate Revenue by Application (2024-2034)
5.2.3 Global Dimenhydrinate Revenue Market Share by Application (2018-2034)
5.3 Global Dimenhydrinate Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Bristol-Myers Squibb Dimenhydrinate Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Baxter Healthcare
6.2.1 Baxter Healthcare Corporation Information
6.2.2 Baxter Healthcare Description and Business Overview
6.2.3 Baxter Healthcare Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Baxter Healthcare Dimenhydrinate Product Portfolio
6.2.5 Baxter Healthcare Recent Developments/Updates
6.3 Watson Laboratories
6.3.1 Watson Laboratories Corporation Information
6.3.2 Watson Laboratories Description and Business Overview
6.3.3 Watson Laboratories Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Watson Laboratories Dimenhydrinate Product Portfolio
6.3.5 Watson Laboratories Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Pfizer Dimenhydrinate Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Nexgen Pharma
6.5.1 Nexgen Pharma Corporation Information
6.5.2 Nexgen Pharma Description and Business Overview
6.5.3 Nexgen Pharma Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Nexgen Pharma Dimenhydrinate Product Portfolio
6.5.5 Nexgen Pharma Recent Developments/Updates
6.6 Goodwill Pharma
6.6.1 Goodwill Pharma Corporation Information
6.6.2 Goodwill Pharma Description and Business Overview
6.6.3 Goodwill Pharma Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Goodwill Pharma Dimenhydrinate Product Portfolio
6.6.5 Goodwill Pharma Recent Developments/Updates
6.7 Hennig Arzneimittel
6.6.1 Hennig Arzneimittel Corporation Information
6.6.2 Hennig Arzneimittel Description and Business Overview
6.6.3 Hennig Arzneimittel Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Hennig Arzneimittel Dimenhydrinate Product Portfolio
6.7.5 Hennig Arzneimittel Recent Developments/Updates
6.8 Zambon
6.8.1 Zambon Corporation Information
6.8.2 Zambon Description and Business Overview
6.8.3 Zambon Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Zambon Dimenhydrinate Product Portfolio
6.8.5 Zambon Recent Developments/Updates
6.9 Apotex
6.9.1 Apotex Corporation Information
6.9.2 Apotex Description and Business Overview
6.9.3 Apotex Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Apotex Dimenhydrinate Product Portfolio
6.9.5 Apotex Recent Developments/Updates
6.10 Teva
6.10.1 Teva Corporation Information
6.10.2 Teva Description and Business Overview
6.10.3 Teva Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Teva Dimenhydrinate Product Portfolio
6.10.5 Teva Recent Developments/Updates
6.11 Mylan
6.11.1 Mylan Corporation Information
6.11.2 Mylan Dimenhydrinate Description and Business Overview
6.11.3 Mylan Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Mylan Dimenhydrinate Product Portfolio
6.11.5 Mylan Recent Developments/Updates
6.12 Cinfa
6.12.1 Cinfa Corporation Information
6.12.2 Cinfa Dimenhydrinate Description and Business Overview
6.12.3 Cinfa Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Cinfa Dimenhydrinate Product Portfolio
6.12.5 Cinfa Recent Developments/Updates
6.13 Neuraxpharm Arzneimittel
6.13.1 Neuraxpharm Arzneimittel Corporation Information
6.13.2 Neuraxpharm Arzneimittel Dimenhydrinate Description and Business Overview
6.13.3 Neuraxpharm Arzneimittel Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Neuraxpharm Arzneimittel Dimenhydrinate Product Portfolio
6.13.5 Neuraxpharm Arzneimittel Recent Developments/Updates
6.14 Gedeon Richter
6.14.1 Gedeon Richter Corporation Information
6.14.2 Gedeon Richter Dimenhydrinate Description and Business Overview
6.14.3 Gedeon Richter Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Gedeon Richter Dimenhydrinate Product Portfolio
6.14.5 Gedeon Richter Recent Developments/Updates
6.15 Medrock Biotech
6.15.1 Medrock Biotech Corporation Information
6.15.2 Medrock Biotech Dimenhydrinate Description and Business Overview
6.15.3 Medrock Biotech Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Medrock Biotech Dimenhydrinate Product Portfolio
6.15.5 Medrock Biotech Recent Developments/Updates
6.16 Strides Pharma
6.16.1 Strides Pharma Corporation Information
6.16.2 Strides Pharma Dimenhydrinate Description and Business Overview
6.16.3 Strides Pharma Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Strides Pharma Dimenhydrinate Product Portfolio
6.16.5 Strides Pharma Recent Developments/Updates
6.17 Fresenius
6.17.1 Fresenius Corporation Information
6.17.2 Fresenius Dimenhydrinate Description and Business Overview
6.17.3 Fresenius Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Fresenius Dimenhydrinate Product Portfolio
6.17.5 Fresenius Recent Developments/Updates
6.18 Novartis
6.18.1 Novartis Corporation Information
6.18.2 Novartis Dimenhydrinate Description and Business Overview
6.18.3 Novartis Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Novartis Dimenhydrinate Product Portfolio
6.18.5 Novartis Recent Developments/Updates
6.19 Johnson and Johnson
6.19.1 Johnson and Johnson Corporation Information
6.19.2 Johnson and Johnson Dimenhydrinate Description and Business Overview
6.19.3 Johnson and Johnson Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Johnson and Johnson Dimenhydrinate Product Portfolio
6.19.5 Johnson and Johnson Recent Developments/Updates
6.20 Yoshindo
6.20.1 Yoshindo Corporation Information
6.20.2 Yoshindo Dimenhydrinate Description and Business Overview
6.20.3 Yoshindo Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Yoshindo Dimenhydrinate Product Portfolio
6.20.5 Yoshindo Recent Developments/Updates
6.21 IFET
6.21.1 IFET Corporation Information
6.21.2 IFET Dimenhydrinate Description and Business Overview
6.21.3 IFET Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.21.4 IFET Dimenhydrinate Product Portfolio
6.21.5 IFET Recent Developments/Updates
6.22 Bayer
6.22.1 Bayer Corporation Information
6.22.2 Bayer Dimenhydrinate Description and Business Overview
6.22.3 Bayer Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Bayer Dimenhydrinate Product Portfolio
6.22.5 Bayer Recent Developments/Updates
6.23 Nidda Healthcare
6.23.1 Nidda Healthcare Corporation Information
6.23.2 Nidda Healthcare Dimenhydrinate Description and Business Overview
6.23.3 Nidda Healthcare Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Nidda Healthcare Dimenhydrinate Product Portfolio
6.23.5 Nidda Healthcare Recent Developments/Updates
6.24 Medifarma
6.24.1 Medifarma Corporation Information
6.24.2 Medifarma Dimenhydrinate Description and Business Overview
6.24.3 Medifarma Dimenhydrinate Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Medifarma Dimenhydrinate Product Portfolio
6.24.5 Medifarma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dimenhydrinate Industry Chain Analysis
7.2 Dimenhydrinate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dimenhydrinate Production Mode & Process
7.4 Dimenhydrinate Sales and Marketing
7.4.1 Dimenhydrinate Sales Channels
7.4.2 Dimenhydrinate Distributors
7.5 Dimenhydrinate Customers
8 Dimenhydrinate Market Dynamics
8.1 Dimenhydrinate Industry Trends
8.2 Dimenhydrinate Market Drivers
8.3 Dimenhydrinate Market Challenges
8.4 Dimenhydrinate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Dimenhydrinate Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Dimenhydrinate Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Dimenhydrinate Market Competitive Situation by Manufacturers in 2022
Table 4. Global Dimenhydrinate Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Dimenhydrinate Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Dimenhydrinate Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Dimenhydrinate Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Dimenhydrinate Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Dimenhydrinate, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Dimenhydrinate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dimenhydrinate, Product Type & Application
Table 12. Global Key Manufacturers of Dimenhydrinate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dimenhydrinate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dimenhydrinate as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dimenhydrinate Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Dimenhydrinate Sales by Region (2018-2024) & (K Units)
Table 18. Global Dimenhydrinate Sales Market Share by Region (2018-2024)
Table 19. Global Dimenhydrinate Sales by Region (2024-2034) & (K Units)
Table 20. Global Dimenhydrinate Sales Market Share by Region (2024-2034)
Table 21. Global Dimenhydrinate Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Dimenhydrinate Revenue Market Share by Region (2018-2024)
Table 23. Global Dimenhydrinate Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Dimenhydrinate Revenue Market Share by Region (2024-2034)
Table 25. North America Dimenhydrinate Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Dimenhydrinate Sales by Country (2018-2024) & (K Units)
Table 27. North America Dimenhydrinate Sales by Country (2024-2034) & (K Units)
Table 28. North America Dimenhydrinate Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Dimenhydrinate Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Dimenhydrinate Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Dimenhydrinate Sales by Country (2018-2024) & (K Units)
Table 32. Europe Dimenhydrinate Sales by Country (2024-2034) & (K Units)
Table 33. Europe Dimenhydrinate Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Dimenhydrinate Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Dimenhydrinate Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Dimenhydrinate Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Dimenhydrinate Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Dimenhydrinate Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Dimenhydrinate Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Dimenhydrinate Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Dimenhydrinate Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Dimenhydrinate Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Dimenhydrinate Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Dimenhydrinate Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Dimenhydrinate Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Dimenhydrinate Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Dimenhydrinate Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Dimenhydrinate Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Dimenhydrinate Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Dimenhydrinate Sales (K Units) by Type (2018-2024)
Table 51. Global Dimenhydrinate Sales (K Units) by Type (2024-2034)
Table 52. Global Dimenhydrinate Sales Market Share by Type (2018-2024)
Table 53. Global Dimenhydrinate Sales Market Share by Type (2024-2034)
Table 54. Global Dimenhydrinate Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Dimenhydrinate Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Dimenhydrinate Revenue Market Share by Type (2018-2024)
Table 57. Global Dimenhydrinate Revenue Market Share by Type (2024-2034)
Table 58. Global Dimenhydrinate Price (US$/Unit) by Type (2018-2024)
Table 59. Global Dimenhydrinate Price (US$/Unit) by Type (2024-2034)
Table 60. Global Dimenhydrinate Sales (K Units) by Application (2018-2024)
Table 61. Global Dimenhydrinate Sales (K Units) by Application (2024-2034)
Table 62. Global Dimenhydrinate Sales Market Share by Application (2018-2024)
Table 63. Global Dimenhydrinate Sales Market Share by Application (2024-2034)
Table 64. Global Dimenhydrinate Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Dimenhydrinate Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Dimenhydrinate Revenue Market Share by Application (2018-2024)
Table 67. Global Dimenhydrinate Revenue Market Share by Application (2024-2034)
Table 68. Global Dimenhydrinate Price (US$/Unit) by Application (2018-2024)
Table 69. Global Dimenhydrinate Price (US$/Unit) by Application (2024-2034)
Table 70. Bristol-Myers Squibb Corporation Information
Table 71. Bristol-Myers Squibb Description and Business Overview
Table 72. Bristol-Myers Squibb Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Bristol-Myers Squibb Dimenhydrinate Product
Table 74. Bristol-Myers Squibb Recent Developments/Updates
Table 75. Baxter Healthcare Corporation Information
Table 76. Baxter Healthcare Description and Business Overview
Table 77. Baxter Healthcare Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Baxter Healthcare Dimenhydrinate Product
Table 79. Baxter Healthcare Recent Developments/Updates
Table 80. Watson Laboratories Corporation Information
Table 81. Watson Laboratories Description and Business Overview
Table 82. Watson Laboratories Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Watson Laboratories Dimenhydrinate Product
Table 84. Watson Laboratories Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Pfizer Dimenhydrinate Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Nexgen Pharma Corporation Information
Table 91. Nexgen Pharma Description and Business Overview
Table 92. Nexgen Pharma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Nexgen Pharma Dimenhydrinate Product
Table 94. Nexgen Pharma Recent Developments/Updates
Table 95. Goodwill Pharma Corporation Information
Table 96. Goodwill Pharma Description and Business Overview
Table 97. Goodwill Pharma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Goodwill Pharma Dimenhydrinate Product
Table 99. Goodwill Pharma Recent Developments/Updates
Table 100. Hennig Arzneimittel Corporation Information
Table 101. Hennig Arzneimittel Description and Business Overview
Table 102. Hennig Arzneimittel Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Hennig Arzneimittel Dimenhydrinate Product
Table 104. Hennig Arzneimittel Recent Developments/Updates
Table 105. Zambon Corporation Information
Table 106. Zambon Description and Business Overview
Table 107. Zambon Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Zambon Dimenhydrinate Product
Table 109. Zambon Recent Developments/Updates
Table 110. Apotex Corporation Information
Table 111. Apotex Description and Business Overview
Table 112. Apotex Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Apotex Dimenhydrinate Product
Table 114. Apotex Recent Developments/Updates
Table 115. Teva Corporation Information
Table 116. Teva Description and Business Overview
Table 117. Teva Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Teva Dimenhydrinate Product
Table 119. Teva Recent Developments/Updates
Table 120. Mylan Corporation Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Mylan Dimenhydrinate Product
Table 124. Mylan Recent Developments/Updates
Table 125. Cinfa Corporation Information
Table 126. Cinfa Description and Business Overview
Table 127. Cinfa Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Cinfa Dimenhydrinate Product
Table 129. Cinfa Recent Developments/Updates
Table 130. Neuraxpharm Arzneimittel Corporation Information
Table 131. Neuraxpharm Arzneimittel Description and Business Overview
Table 132. Neuraxpharm Arzneimittel Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Neuraxpharm Arzneimittel Dimenhydrinate Product
Table 134. Neuraxpharm Arzneimittel Recent Developments/Updates
Table 135. Gedeon Richter Corporation Information
Table 136. Gedeon Richter Description and Business Overview
Table 137. Gedeon Richter Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Gedeon Richter Dimenhydrinate Product
Table 139. Gedeon Richter Recent Developments/Updates
Table 140. Medrock Biotech Corporation Information
Table 141. Medrock Biotech Description and Business Overview
Table 142. Medrock Biotech Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Medrock Biotech Dimenhydrinate Product
Table 144. Medrock Biotech Recent Developments/Updates
Table 145. Strides Pharma Corporation Information
Table 146. Strides Pharma Description and Business Overview
Table 147. Strides Pharma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Strides Pharma Dimenhydrinate Product
Table 149. Strides Pharma Recent Developments/Updates
Table 150. Fresenius Corporation Information
Table 151. Fresenius Description and Business Overview
Table 152. Fresenius Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Fresenius Dimenhydrinate Product
Table 154. Fresenius Recent Developments/Updates
Table 155. Novartis Corporation Information
Table 156. Novartis Description and Business Overview
Table 157. Novartis Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Novartis Dimenhydrinate Product
Table 159. Novartis Recent Developments/Updates
Table 160. Johnson and Johnson Corporation Information
Table 161. Johnson and Johnson Description and Business Overview
Table 162. Johnson and Johnson Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Johnson and Johnson Dimenhydrinate Product
Table 164. Johnson and Johnson Recent Developments/Updates
Table 165. Yoshindo Corporation Information
Table 166. Yoshindo Description and Business Overview
Table 167. Yoshindo Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Yoshindo Dimenhydrinate Product
Table 169. Yoshindo Recent Developments/Updates
Table 170. IFET Corporation Information
Table 171. IFET Description and Business Overview
Table 172. IFET Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. IFET Dimenhydrinate Product
Table 174. IFET Recent Developments/Updates
Table 175. Bayer Corporation Information
Table 176. Bayer Description and Business Overview
Table 177. Bayer Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Bayer Dimenhydrinate Product
Table 179. Bayer Recent Developments/Updates
Table 180. Nidda Healthcare Corporation Information
Table 181. Nidda Healthcare Description and Business Overview
Table 182. Nidda Healthcare Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Nidda Healthcare Dimenhydrinate Product
Table 184. Nidda Healthcare Recent Developments/Updates
Table 185. Medifarma Corporation Information
Table 186. Medifarma Description and Business Overview
Table 187. Medifarma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Medifarma Dimenhydrinate Product
Table 189. Medifarma Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Dimenhydrinate Distributors List
Table 193. Dimenhydrinate Customers List
Table 194. Dimenhydrinate Market Trends
Table 195. Dimenhydrinate Market Drivers
Table 196. Dimenhydrinate Market Challenges
Table 197. Dimenhydrinate Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dimenhydrinate
Figure 2. Global Dimenhydrinate Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Dimenhydrinate Market Share by Type in 2022 & 2034
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Dimenhydrinate Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Dimenhydrinate Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. On-line
Figure 11. Global Dimenhydrinate Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Dimenhydrinate Market Size (2018-2034) & (US$ Million)
Figure 13. Global Dimenhydrinate Sales (2018-2034) & (K Units)
Figure 14. Global Dimenhydrinate Average Price (US$/Unit) & (2018-2034)
Figure 15. Dimenhydrinate Report Years Considered
Figure 16. Dimenhydrinate Sales Share by Manufacturers in 2022
Figure 17. Global Dimenhydrinate Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Dimenhydrinate Players: Market Share by Revenue in 2022
Figure 19. Dimenhydrinate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Dimenhydrinate Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America Dimenhydrinate Sales Market Share by Country (2018-2034)
Figure 22. North America Dimenhydrinate Revenue Market Share by Country (2018-2034)
Figure 23. United States Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Dimenhydrinate Sales Market Share by Country (2018-2034)
Figure 26. Europe Dimenhydrinate Revenue Market Share by Country (2018-2034)
Figure 27. Germany Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Dimenhydrinate Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Dimenhydrinate Revenue Market Share by Region (2018-2034)
Figure 34. China Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Dimenhydrinate Sales Market Share by Country (2018-2034)
Figure 44. Latin America Dimenhydrinate Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Dimenhydrinate Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Dimenhydrinate Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Dimenhydrinate Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Dimenhydrinate by Type (2018-2034)
Figure 54. Global Revenue Market Share of Dimenhydrinate by Type (2018-2034)
Figure 55. Global Dimenhydrinate Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Dimenhydrinate by Application (2018-2034)
Figure 57. Global Revenue Market Share of Dimenhydrinate by Application (2018-2034)
Figure 58. Global Dimenhydrinate Price (US$/Unit) by Application (2018-2034)
Figure 59. Dimenhydrinate Value Chain
Figure 60. Dimenhydrinate Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed